Literature DB >> 8087515

Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.

T Le Chevalier1, R Arriagada, E Quoix, P Ruffie, M Martin, J Y Douillard, M Tarayre, M J Lacombe-Terrier, A Laplanche.   

Abstract

We report the results observed in a large randomized study comparing radiotherapy alone to combined radiotherapy and chemotherapy in unresectable squamous cell and large cell lung carcinoma. Radiation dose was 65 Gy in both groups and chemotherapy included vindesine, cyclophosphamide, cisplatin and lomustine. One hundred seventy-seven patients received radiotherapy alone, and 176 received the combined treatment. The 2-year survival rate was 14% for patients receiving radiotherapy vs. 21% for patients receiving the combined treatment (P = 0.02). The distant metastasis rate was significantly lower in the group receiving the combined treatment (P < 0.001). Local control at 1 year was poor in both groups (17% and 15%, respectively) and remains a major problem in locally advanced non-small cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087515     DOI: 10.1016/0169-5002(94)91687-x

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  25 in total

1.  A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response.

Authors:  Ramesh Rengan; Rosemarie Mick; Daniel Pryma; Mark A Rosen; Lilie L Lin; Amit M Maity; Tracey L Evans; James P Stevenson; Corey J Langer; John Kucharczuk; Joseph Friedberg; Susan Prendergast; Tiffany Sharkoski; Stephen M Hahn
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

2.  Inoperable stage III non-small cell lung cancer: Current treatment and role of vinorelbine.

Authors:  Mariano Provencio; Dolores Isla; Antonio Sánchez; Blanca Cantos
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

3.  Improved local control without elective nodal radiotherapy in patients with unresectable NSCLC treated by 3D-CRT.

Authors:  Kunyu Yang; Fengjun Cao; Jianhua Wang; Li Liu; Tao Zhang; Gang Wu
Journal:  Front Med China       Date:  2007-10-01

4.  PACIFIC trial: new perspectives for immunotherapy in lung cancer.

Authors:  Francesco Agustoni; Fred R Hirsch
Journal:  Transl Lung Cancer Res       Date:  2018-02

Review 5.  Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer.

Authors:  Salma K Jabbour; Abigail T Berman; Charles B Simone
Journal:  Transl Lung Cancer Res       Date:  2017-04

6.  Repopulation of interacting tumor cells during fractionated radiotherapy: stochastic modeling of the tumor control probability.

Authors:  Hatim Fakir; Lynn Hlatky; Huamin Li; Rainer Sachs
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

7.  Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.

Authors:  Mitchell Machtay; Fenghai Duan; Barry A Siegel; Bradley S Snyder; Jeremy J Gorelick; Janet S Reddin; Reginald Munden; Douglas W Johnson; Larry H Wilf; Albert DeNittis; Nancy Sherwin; Kwan Ho Cho; Seok-Ki Kim; Gregory Videtic; Donald R Neumann; Ritsuko Komaki; Homer Macapinlac; Jeffrey D Bradley; Abass Alavi
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

Review 8.  Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.

Authors:  Matthew J Krasin; Louis S Constine; Debra L Friedman; Lawrence B Marks
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

9.  Pros: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable stage III non-small cell lung cancer.

Authors:  Bryan M Rabatic; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2016-04

10.  The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients.

Authors:  Ji-Yoon Kim; Yeon-Sil Kim; Young-Kyoon Kim; Hyun-Jin Park; Seung-Joon Kim; Jin-Hyoung Kang; Young-Pil Wang; Hong-Seok Jang; Sang-Nam Lee; Sei-Chul Yoon
Journal:  Radiat Oncol       Date:  2009-11-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.